布罗利祖马布诱导的胆管炎的临床特征,治疗和结果
Weilun Fang1,2, Wei Sun1, Weijin Fang1
1Department of Pharmacy, The Third Xiangya Hospital, Central South University, No. 138 Tongzipo Road, YueLu District, Changsha, 410013, Hunan, China.
Naunyn-Schmiedeberg's archives of pharmacology
|May 15, 2024
概括
布罗利祖马布可以引起胆管炎,这是一个罕见但严重的副作用. 这项研究分析了50名患者,发现胆道酶升高和成像变化,对类固醇反应有限,但对ursodeoxycholic acid有潜在的益处.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 布罗利祖马布诱导的肝炎已被认可,但胆炎仍然不太了解.
- 胆管炎作为免疫检查点抑制剂 (ICI) 的免疫相关不良事件 (irAE) 需要进一步调查.
- 了解pembrolizumab诱导的胆管炎的临床谱对于及时诊断和管理至关重要.
研究的目的:
- 为了研究临床特征,治疗策略和患者经历胆管炎二次性到 pembrolizumab 治疗的结果.
- 描述与pembrolizumab诱导的胆管炎相关的诊断发现,包括实验室值和成像结果.
- 为了评估不同治疗方式的疗效,如免疫抑制和乌尔索氧胆酸,在管理这种情况.
主要方法:
- 在英语和中文数据库中进行了全面的文献搜索,截至2023年10月30日,以确定相关的病例报告,病例系列和临床研究.
- 50名被诊断患有布罗利祖马布诱导的胆管炎的患者被纳入了分析.
- 收集和分析了临床数据,包括人口统计数据,发病时间,症状,实验室发现 (胆管酶),成像特征,组织病理学和治疗反应.
主要成果:
- 50名患者的中位数年龄为68岁,在 pembrolizumab 开始后的 1.1 个月中位数发病.
- 大多数患者表现为胆汁酶升高 (48.0%),而其他患者表现为黄 (24.0%),腹痛 (20.0%),或发烧 (14.0%).
- 免疫抑制治疗在8.0%的患者中产生了完全响应,在56.0%的患者中产生了部分响应,在30.0%的患者中产生了不良响应,这表明在许多情况下类固醇的有效性有限. 乌尔索多西胆酸显示出作为替代治疗方法的潜力.
结论:
- 布罗利祖马布诱导的胆脉炎是一种罕见但严重的irAE,需要临床警.
- 升高的胆汁酶和特征性成像发现是关键的诊断指标.
- 虽然免疫抑制可能提供部分益处,但ursodeoxycholic 酸为管理布罗利祖马布诱导的胆管炎提供了潜在的治疗选择.
相关概念视频
Chronic Bowel Disorders: Introduction
445
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
445
Chronic Pancreatitis II: Collaborative Care
85
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
85
Chronic Pancreatitis I: Introduction
87
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
87
Acute Pancreatitis II: Clinical Manifestations and Management
122
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122
Inflammatory Bowel Disease I: Ulcerative Colitis
166
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
166
Endoscopic Procedures V: ERCP
196
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
196


